Slingshot members are tracking this event:
Phase 1/2 data of IMO-8400 for patients with DLBCL who harbor the MYD88 L265P mutation due 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|IDRA||Community voting in process|
Slingshot Insights Explained
Sep 26, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 1/2 Data, Imo-8400, Dlbcl, Myd88 L265p Mutation